Targeting the PDGF signaling pathway in tumor treatment
CH Heldin - Cell Communication and Signaling, 2013 - Springer
Platelet-derived growth factor (PDGF) isoforms and PDGF receptors have important
functions in the regulation of growth and survival of certain cell types during embryonal …
functions in the regulation of growth and survival of certain cell types during embryonal …
PDGF and PDGF receptors in glioma
I Nazarenko, SM Hede, X He, A Hedrén… - Upsala journal of …, 2012 - Taylor & Francis
The family of platelet-derived growth factors (PDGFs) plays a number of critical roles in
normal embryonic development, cellular differentiation, and response to tissue damage. Not …
normal embryonic development, cellular differentiation, and response to tissue damage. Not …
[HTML][HTML] Early clonal extinction in glioblastoma progression revealed by genetic barcoding
D Ceresa, F Alessandrini, S Lucchini, D Marubbi… - Cancer Cell, 2023 - cell.com
Glioblastoma progression in its early stages remains poorly understood. Here, we transfer
PDGFB and genetic barcodes in mouse brain to initiate gliomagenesis and enable direct …
PDGFB and genetic barcodes in mouse brain to initiate gliomagenesis and enable direct …
Oncolytic herpes simplex viruses for the treatment of glioma and targeting glioblastoma stem-like cells
K Kardani, J Sanchez Gil, SD Rabkin - Frontiers in Cellular and …, 2023 - frontiersin.org
Glioblastoma (GBM) is one of the most lethal cancers, having a poor prognosis and a
median survival of only about 15 months with standard treatment (surgery, radiation, and …
median survival of only about 15 months with standard treatment (surgery, radiation, and …
Sox2 is required to maintain cancer stem cells in a mouse model of high-grade oligodendroglioma
R Favaro, I Appolloni, S Pellegatta, AB Sanga… - Cancer research, 2014 - AACR
The stem cell–determining transcription factor Sox2 is required for the maintenance of
normal neural stem cells. In this study, we investigated the requirement for Sox2 in neural …
normal neural stem cells. In this study, we investigated the requirement for Sox2 in neural …
The plasticity of oncogene addiction: implications for targeted therapies directed to receptor tyrosine kinases
V Pillay, L Allaf, AL Wilding, JF Donoghue, NW Court… - Neoplasia, 2009 - Elsevier
A common mutation of the epidermal growth factor receptor (EGFR) in glioblastoma
multiforme (GBM) is an extracellular truncation known as the de2-7 EGFR (or EGFRvIII) …
multiforme (GBM) is an extracellular truncation known as the de2-7 EGFR (or EGFRvIII) …
[HTML][HTML] Patterns of invasive growth in malignant gliomas—the hippocampus emerges as an invasion-spared brain region
AA Mughal, L Zhang, A Fayzullin, A Server, Y Li, Y Wu… - Neoplasia, 2018 - Elsevier
BACKGROUND: Widespread infiltration of tumor cells into surrounding brain parenchyma is
a hallmark of malignant gliomas, but little data exist on the overall invasion pattern of tumor …
a hallmark of malignant gliomas, but little data exist on the overall invasion pattern of tumor …
Programming a Ferroptosis‐to‐Apoptosis Transition Landscape Revealed Ferroptosis Biomarkers and Repressors for Cancer Therapy
Ferroptosis and apoptosis are key cell‐death pathways implicated in several human
diseases including cancer. Ferroptosis is driven by iron‐dependent lipid peroxidation and …
diseases including cancer. Ferroptosis is driven by iron‐dependent lipid peroxidation and …
Safety of recombinant human platelet-derived growth factor-BB in Augment® Bone Graft
LA Solchaga, CK Hee, S Roach… - Journal of tissue …, 2012 - journals.sagepub.com
This article discusses nonclinical and clinical data regarding the safety of recombinant
human platelet-derived growth factor-BB as a component of the Augment® Bone Graft …
human platelet-derived growth factor-BB as a component of the Augment® Bone Graft …
Breast tumor progression induced by loss of BTG2 expression is inhibited by targeted therapy with the ErbB/HER inhibitor lapatinib
F Takahashi, N Chiba, K Tajima, T Hayashida… - Oncogene, 2011 - nature.com
The B-cell translocation gene-2 (BTG2), a p53-inducible gene, is suppressed in mammary
epithelial cells during gestation and lactation. In human breast cancer, decreased BTG2 …
epithelial cells during gestation and lactation. In human breast cancer, decreased BTG2 …